The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictors of outcome in patients with recurrent/metastatic head and neck squamous cell carcinomas (RMHNSCC) treated with weekly cetuximab and paclitaxel (CP).
 
Bruna Pellini Ferreira
No Relationships to Disclose
 
Kelsey K. Baker
No Relationships to Disclose
 
Mary Redman
No Relationships to Disclose
 
Renato Martins
Research Funding - Astex Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); OSI Pharmaceuticals (Inst); Pfizer (Inst); VentiRx (Inst)
 
Keith D. Eaton
No Relationships to Disclose
 
Laura Quan Man Chow
Honoraria - Astellas Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly/ImClone (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); VentiRx (Inst)
Travel, Accommodations, Expenses - Merck; Novartis
 
Christina S. Baik
No Relationships to Disclose
 
Bernardo Goulart
No Relationships to Disclose
 
Sylvia Mina Lee
No Relationships to Disclose
 
Rafael Santana-Davila
No Relationships to Disclose
 
Cristina P. Rodriguez
No Relationships to Disclose